130 related articles for article (PubMed ID: 6163105)
1. Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats.
Fuller RW; Snoddy HD; Mason NR; Owen JE
Neuropharmacology; 1981 Feb; 20(2):155-62. PubMed ID: 6163105
[No Abstract] [Full Text] [Related]
2. Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptors.
Fuller RW; Mason NR
Adv Exp Med Biol; 1981; 133():359-68. PubMed ID: 6172017
[No Abstract] [Full Text] [Related]
3. The influence of quipazine on the turnover rate of serotonin.
Grabowska M; Antkiewicz L; Michaluk J
Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
[No Abstract] [Full Text] [Related]
4. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
[No Abstract] [Full Text] [Related]
5. Neurochemical effects of ET 495 : mechanism of action.
Hiremagalur J; Keshavan H; Gurbani NK; Dandiya PC
Pharmacol Res Commun; 1981 Jun; 13(6):607-15. PubMed ID: 6170078
[No Abstract] [Full Text] [Related]
6. Brain serotonin metabolism after tolerance dosage of LSD.
Freedman DX; Boggan WO
Adv Biochem Psychopharmacol; 1974; 10():151-7. PubMed ID: 4846536
[No Abstract] [Full Text] [Related]
7. Effects of altered brain 5-hydroxytryptaminergic activity on brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.
Marsden CA; Curzon G
Neuropharmacology; 1976 Nov; 15(11):703-8. PubMed ID: 1004692
[No Abstract] [Full Text] [Related]
8. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
Fuller RW; Mason NR; Snoddy HD; Perry KW
Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
[TBL] [Abstract][Full Text] [Related]
9. Studies on the biochemical and behavioural effects of oral nicotine.
Balfour DJ
Arch Int Pharmacodyn Ther; 1980 May; 245(1):95-103. PubMed ID: 6157372
[TBL] [Abstract][Full Text] [Related]
10. Factors modulating brain serotonin turnover.
Diaz PM; Ngai SH; Costa E
Adv Pharmacol (1962); 1968; 6(Pt B):75-92. PubMed ID: 5658336
[No Abstract] [Full Text] [Related]
11. Persistent effects of repeated injections of D-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels.
Peters DA; Tang S
Biochem Pharmacol; 1977 Jun; 26(11):1085-6. PubMed ID: 880261
[No Abstract] [Full Text] [Related]
12. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
King AR; Martin IL; Melville KA
Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
[TBL] [Abstract][Full Text] [Related]
13. Effects of morpholino-, pyrrolidino-, piperizino-, and cyclo-octyl-derivatives of beta-alanine on brain amines and amino acids.
Leonard BE; Liska KJ
Life Sci I; 1971 Jan; 10(2):93-104. PubMed ID: 5575407
[No Abstract] [Full Text] [Related]
14. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
[No Abstract] [Full Text] [Related]
15. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats.
Aulakh CS; Wozniak KM; Hill JL; Devane CL; Tolliver TJ; Murphy DL
Neuroendocrinology; 1988 Oct; 48(4):401-6. PubMed ID: 2463494
[TBL] [Abstract][Full Text] [Related]
16. Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine.
Rosecrans JA; Lovell RA; Freedman DX
Biochem Pharmacol; 1967 Oct; 16(10):2011-21. PubMed ID: 6065966
[No Abstract] [Full Text] [Related]
17. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
Maj J; Pawlowski L; Sarnek J
Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
[No Abstract] [Full Text] [Related]
18. Comparative effects of p-chloroamphetamine and 1-(p-chlorophenyl)piperazine on 5-hydroxyindole concentration in rat brain.
Fuller RW; Snoddy HD
Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):201-4. PubMed ID: 6157183
[TBL] [Abstract][Full Text] [Related]
19. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
Jacoby JH; Poulakos JJ
J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
[No Abstract] [Full Text] [Related]
20. Studies on the concurrent behavioral and neurochemical effects of psychoactive drugs using the push-pull cannula.
Tilson HA; Sparber SB
J Pharmacol Exp Ther; 1972 Jun; 181(3):387-98. PubMed ID: 5033008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
